The Sonoran Desert toad secretes 5-MeO-DMT, a potent psychedelic compound currently being investigated as a potential treatment for depression. However, ongoing clinical trials face significant methodological challenges, including short observation periods and difficulties in maintaining double-blind conditions. Due to the toads' high toxicity to pets and the ethical concerns of harvesting them, experts strongly advocate for synthesizing the compound in a laboratory instead.